- Masitinib as an adjunct therapy for mild-to-moderate Alzheimer's disease: a randomised, placebo-controlled phase 2 trialFrançois Piette
Hopital Charles Foix, Service de Medecine, Bâtiment Louis Ramond, 7 avenue de la Republique, 94205 Ivry sur Seine, France
Alzheimers Res Ther 3:16. 2011..As the brain is rich in mast cells, the therapeutic potential of masitinib as an adjunct therapy to standard care was investigated...
- [Abridged version of the severe impairment battery (SIB)]Laurence Hugonot-Diener
Groupe de travail démence sévère du GRECO, Medforma, Paris
Psychol Neuropsychiatr Vieil 1:273-83. 2003..Finally the selection was justified by a factorial analysis. The present version is based on a consensus reached by an US and Italian research group, in addition to ours...
- The functional locus of intrusions: encoding or retrieval?Gianfranco Dalla Barba
U 324 INSERM, Paris, France
J Clin Exp Neuropsychol 24:633-41. 2002..These results suggest that encoding processes, more than retrieval processes, have a role in eliciting intrusions...
- Development of a short form of the Severe Impairment BatteryJudith Saxton
Univ of Pittsburgh, Pittsburgh, PA, USA
Am J Geriatr Psychiatry 13:999-1005. 2005..The authors sought to develop a short form of the Severe Impairment Battery (SIB)...